Chiam Patrick J T, Chan Jin H, Haider Syed I, Karia Niral, Kasaby Hosam, Aggarwal Rajesh K
Southend University Hospital NHS Foundation Trust, Southend-on-Sea, Essex, United Kingdom.
J Cataract Refract Surg. 2007 Dec;33(12):2057-61. doi: 10.1016/j.jcrs.2007.07.029.
To compare the visual outcomes in patients with bilateral implantation of AcrySof ReSTOR multifocal intraocular lenses (IOLs) (Alcon Laboratories) or ReZoom multifocal IOLs (Advanced Medical Optics) 6 months after cataract surgery.
Orsett and Southend Hospital, Essex, United Kingdom.
This study comprised patients who had uneventful bilateral cataract extraction with implantation of ReZoom (n = 50) or ReSTOR (n = 50) multifocal IOLs. Parameters analyzed included binocular uncorrected distance, intermediate, and near acuities; spectacle independence; subjective visual symptoms; and patient satisfaction. All parameters were evaluated 6 months after second-eye surgery.
All patients had binocular uncorrected distance visual acuity of 20/32 or better; there was no statistically significant difference between the 2 groups. The mean binocular uncorrected near acuity was 20/26 (J1.22) in the ReSTOR group and 20/34 (J2.34) in the ReZoom group (P<.0001). The mean binocular uncorrected intermediate visual acuity was 20/42 and 20/34, respectively (P = .003). Patients in the ReZoom group reported greater satisfaction with intermediate vision (P = .04). No statistically significant difference was found in satisfaction with near vision. Eighty-six percent of ReSTOR patients and 70% of ReZoom patients did not wear glasses for daily activities; the overall satisfaction was not statistically significantly different between groups. There was no significant difference between groups in photic phenomena.
The ReSTOR IOL provided better near vision and the ReZoom IOL better intermediate vision. Both multifocal IOLs gave excellent distance vision. Photic phenomena were comparable and clinically acceptable. ReSTOR patients had greater spectacle independence for near vision and ReZoom patients for intermediate vision. Overall spectacle independence was not statistically significantly different.
比较白内障手术后6个月,双侧植入爱尔康公司的AcrySof ReSTOR多焦点人工晶状体(IOL)或眼力健公司的ReZoom多焦点IOL患者的视觉效果。
英国埃塞克斯郡奥赛特和绍森德医院。
本研究纳入了双侧白内障摘除并植入ReZoom(n = 50)或ReSTOR(n = 50)多焦点IOL且手术过程顺利的患者。分析的参数包括双眼未矫正的远、中、近视力;无需配镜情况;主观视觉症状;以及患者满意度。所有参数均在第二只眼手术后6个月进行评估。
所有患者双眼未矫正远视力均达到20/32或更好;两组之间无统计学显著差异。ReSTOR组双眼未矫正近视力平均为20/26(J1.22),ReZoom组为20/34(J2.34)(P<0.0001)。双眼未矫正中视力平均分别为20/42和20/34(P = 0.003)。ReZoom组患者对中视力的满意度更高(P = 0.04)。近视力满意度方面未发现统计学显著差异。86%的ReSTOR患者和70%的ReZoom患者在日常活动中无需佩戴眼镜;两组总体满意度无统计学显著差异。两组在光现象方面无显著差异。
ReSTOR IOL提供了更好的近视力,ReZoom IOL提供了更好的中视力。两种多焦点IOL均提供了出色的远视力。光现象相当且临床可接受。ReSTOR患者在近视力方面无需配镜的程度更高,ReZoom患者在中视力方面更高。总体无需配镜情况无统计学显著差异。